The global Injectable Drug Delivery Market, valued at US$633.7 billion in 2024, is forecasted to grow at a robust CAGR of 8.4 ...

The global Injectable Drug Delivery Market, valued at US$633.7 billion in 2024, is forecasted to grow at a robust CAGR of 8.4%, reaching US$690.23 ...

Fresh off earning FDA approval for a prefilled syringe version of Vyvgart Hytrulo for at-home administration, argenx is building buzz with a new direct-to-consumer campaign. The “Treatment MY ...

Additionally, the recent US approval of Vyvgart Hytrulo as a prefilled syringe for self-injection further enhances patient access and convenience compared with the intravenous infusion of Vyvgart.

The desire for patients to have a personalized approach to care is repeated throughout the ad, which was produced by Avalere ...

The plant, which will mark Roche’s second for branded medicines in the country, will mainly be used for domestic production of the eye med Vabysmo, which goes by the commercial moniker Luoshijia ...

The company continues to build momentum with its innovative agenda and recently launched a pre-filled syringe for self-injection in the U.S. and Germany. CFO Karl Gubitz reported total operating ...

single-dose prefilled syringes. Zydus’ generic Glatiramer Acetate Injection is an FDA-approved, AP-rated substitutable generics of Copaxone ® 20 mg/ml, 40 mg/ml and indicated for the treatment ...

Key market trends include the increasing adoption of wearable injectors, autoinjectors, and needle-free systems. This shift is largely driven by a growing emphasis on patient compliance and home ...

“Now the limitation with that is you can only put in so much drug into the subcutaneous space using a prefilled syringe or auto injector. And a lot of that's believed to be about two milliliters to be ...

Hunter, Device Engineering Manager from GSK, when she participates on a panel debate at Pre-Filled Syringes Europe 2018 alongside West Pharmaceutical Services, Novartis Pharma AG and Merck.